Abbott’s Results Are Solid In Spite of Currency Headwinds
Global pharmaceutical firm Abbott reported strong second-quarter results Wednesday. We think the shares are fairly valued.
Exclusive Analysis for the Discerning Investor
Exclusive Analysis for the Discerning Investor
Global pharmaceutical firm Abbott reported strong second-quarter results Wednesday. We think the shares are fairly valued.